Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
This report aims to provide a comprehensive presentation of the global market for Biobanking, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biobanking. This report contains market size and forecasts of Biobanking in global, including the following market information:
Global Biobanking Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Biobanking market was valued at US$ 3020 million in 2022 and is projected to reach US$ 4724.9 million by 2029, at a CAGR of 6.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
We surveyed the Biobanking companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biobanking Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biobanking Market Segment Percentages, by Type, 2022 (%)
Global Biobanking Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biobanking Market Segment Percentages, by Application, 2022 (%)
- Virtual Biobanks
- Tissue Biobanks
- Population Biobanks
Global Biobanking Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biobanking Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biobanking revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Biobanking revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher
- Beckman Coulter
- Panasonic
- SOL Group
- Promega
- Merck
- Greiner Bio One
- Chart Industries
- Brooks Life Science
- Tecan Group
- QIAGEN
- BD
- Lifeline Scientific
- Hamilton
- So-Low
- TTP Labtech Ltd
- Biolife Solutions
- DNA Genotek
- Custom Biogenic Systems
- LVL Technologies
- BioRep
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Biobanking, market overview.
- Chapter 2: Global Biobanking market size in revenue.
- Chapter 3: Detailed analysis of Biobanking company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Biobanking in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
